Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the "Ligue Contre l'Obésité".
France
obesity
overweight
prevalence
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Jan 2023
25 Jan 2023
Historique:
received:
02
12
2022
revised:
16
01
2023
accepted:
20
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
Obepi-Roche 2020 by the "Ligue Contre l'Obésité" (League Against Obesity) estimated overweight and obesity prevalence in France. The adopted methodology was chosen to be as similar as possible to that of a series of quota-based surveys conducted every three years from 1997 to 2012 (Obepi-Roche studies). The 2020 survey was conducted online from 24th September to 5th October 2020 by the Odoxa polling institute on a sample of metropolitan French subjects aged 18 years or over. Participants (
Identifiants
pubmed: 36769573
pii: jcm12030925
doi: 10.3390/jcm12030925
pmc: PMC9918095
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ligue Contre l'Obésité
ID : No grant number
Références
Diabetes Metab. 2015 Feb;41(1):55-61
pubmed: 25544682
Nutr Rev. 2012 Jan;70(1):3-21
pubmed: 22221213
Int J Obes Relat Metab Disord. 2000 Sep;24(9):1111-8
pubmed: 11033979
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
SSM Popul Health. 2019 May 10;7:100405
pubmed: 31193386
Lancet. 2019 Feb 23;393(10173):791-846
pubmed: 30700377
Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 1):154-8
pubmed: 11994680
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Obesity (Silver Spring). 2008 Sep;16(9):2182-6
pubmed: 18535547
Eur J Epidemiol. 2015 Dec;30(12):1317-28
pubmed: 26520638
Sci Rep. 2021 Jul 8;11(1):14152
pubmed: 34238998
Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-359
pubmed: 33932335
Lancet Diabetes Endocrinol. 2020 Jul;8(7):562-564
pubmed: 32437642